
Regulatory Affairs professional with 7+ years of progressive experience supporting Class I, Class II, and Class III medical devices representing Cardiovascular Diagnostic devices and Laboratory developed tests (LDTs). Proven leader in developing and executing global regulatory and quality strategies to enable new product introductions, sustain marketed products, and ensure compliance with FDA QSR (21 CFR 820), ISO 13485, EU MDR, and ISO 14971. Extensive experience preparing and managing FDA submissions (510(k), PMA support), EU Technical Files, global registrations, labeling compliance, and post-market activities. Recognized for cross-functional leadership, audit readiness, regulatory risk management, and continuous improvement, with a strong ability to influence product development, manufacturing, and commercialization decisions. Strong working knowledge on Global Medical QA & Regulatory requirements and registration procedures including all IFU, UDI, GTIN, and preparing documents for legalization, apostille, and notarization. Complaint investigation & handling specialist - CAPA experienced (Filing and monitoring customer complaints).
FDA 21 CFR Part 820 (QSR/QMSR readiness) EU MDR/IVDR Strategy Support Change Impact Assessment cGMP cGDP ISO 13485 ICH Guidelines Risk Management (ISO 14971, CAPA, RCA, FMEA) PMS/PMCF Technical and Regulatory Writing eQMS governance (Trackwise, DotCompliance, MasterControl) Digital Systems & Analytics (RIMS, RegDesk, SAP, Oracle Agile, SharePoint, REDCap, Adobe InDesign, Tableau (Quality and Regulatory KPIs))